Rodenticides are currently the only viable tool for managing rodent populations at scale—but the most effective second-generation anticoagulant rodenticides (SGARs) are now under critical regulatory pressure. Faced with accelerating bans across at least four US states, British Columbia, and pending PFAS restrictions, the European Union has formally designated SGARs as "candidates for substitution." These escalating global restrictions present an immediate and direct threat to pest control companies’ ability to protect public health and manage rodent infestations effectively.
The Rodenticide Alternatives Program will mobilize over $4M in philanthropic commitments to pioneer non-toxic, taxa-specific immunocontraceptives and chemosterilants. By partnering with established pest control companies for field trials, advance procurement, and technical insights, the program will accelerate the deployment of high-scale, humane alternatives that satisfy rising consumer demand and outpace tightening environmental regulations.